TaiwanJ Pharmaceuticals Co., Ltd. (TPEX:6549)
Taiwan · Delayed Price · Currency is TWD 7.09
+0.06 (0.85%)
Aug 13, 2026, 1:35 PM CST
TaiwanJ Pharmaceuticals Market Cap
TaiwanJ Pharmaceuticals has a market cap or net worth of 563.26 million as of August 13, 2026. Its market cap has decreased by -9.87% in one year.
Market Cap
563.26M
Enterprise Value
497.22M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
7.09
ChartMarket Cap Chart
Since October 21, 2015, TaiwanJ Pharmaceuticals's market cap has decreased from 2.26B to 563.26M, a decrease of -75.03%. That is a compound annual growth rate of -12.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 563.26M | -8.82% |
| Dec 31, 2025 | 617.74M | -5.98% |
| Dec 31, 2024 | 657.00M | -40.71% |
| Dec 29, 2023 | 1.11B | 39.15% |
| Dec 30, 2022 | 796.29M | 4.93% |
| Dec 30, 2021 | 758.89M | -24.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Holy Stone Healthcare | 978.03M |
| Meribank Biotech | 931.93M |
| TCI GENE | 899.59M |
| Taiwan Advance Bio-Pharmaceutical | 836.10M |
| NatureWise Biotech & Medicals | 798.52M |
| BioLASCO Taiwan | 737.63M |
| Neith | 710.20M |
| MegaPro Biomedical | 698.99M |